Related Experiment Videos
Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study
Leo H Jacobs1, Jos J van de Kerkhof, Alma M Mingels
1Department of Clinical Chemistry, University Hospital Maastricht, Maastricht, the Netherlands. leo.jacobs@mumc.nl
Insights
Body composition impacts cardiac biomarkers in hemodialysis patients. Fluid distribution, malnutrition, and inflammation are linked to natriuretic peptides and cardiac markers, suggesting potential for intervention.
Area of Science:
- Nephrology
- Cardiology
- Biomarkers
Background:
- Inflammation, overhydration, and elevated cardiac biomarkers impact outcomes in hemodialysis (HD) patients.
- Longitudinal relationships between body composition (BC), inflammation, and cardiac biomarkers in HD patients require further exploration.
Purpose of the Study:
- To investigate the longitudinal relationship between body composition (BC) and cardiac biomarker concentrations in hemodialysis patients.
- To explore the interplay between body composition, inflammation, and cardiac biomarkers in the HD population.
Main Methods:
- 44 HD patients were followed for 6 months.
- Body composition assessed using multifrequency bioimpedance (BIA).
- Serum concentrations of cardiac troponin T (cTnT), hsCRP, BNP, and NT-proBNP measured bi-monthly; longitudinal analysis using a marginal model.
Main Results:
- BC parameters significantly predicted BNP and NT-proBNP, independent of gender, time, hsCRP, and cTnT.
- Intracellular water/body weight ratio (malnutrition indicator) negatively affected BNP/NT-proBNP; extracellular water/body weight ratio (overhydration indicator) positively affected them.
- HsCRP and cTnT were associated; NT-proBNP predicted cTnT and hsCRP.
Conclusions:
- BIA-derived BC parameters significantly correlate with natriuretic peptide concentrations in HD patients.
- Natriuretic peptide levels may be modifiable by altering fluid distribution, irrespective of cardiac history.
- A complex relationship exists between overhydration, malnutrition, inflammation, and cardiac biomarkers in dialysis patients.
Background:
Inflammation, overhydration and elevated cardiac biomarkers are related to outcome in haemodialysis (HD) patients. Here, we explored the relationship between the body composition (BC), inflammation and cardiac biomarker concentrations in HD patients longitudinally.
Methods:
A total of 44 HD patients were followed for 6 months. BC was assessed by multifrequency bioimpedance (BIA). Serum concentrations of cardiac troponin T (cTnT), high-sensitive C-reactive protein (hsCRP), brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) were assessed at 2 monthly intervals. The longitudinal data analysis was conducted with a marginal model.
Results:
During the follow-up, the parameters describing the BC were highly predictive of both BNP and NT-proBNP and independent of gender, time, hsCRP and cTnT concentrations. The intracellular water (ICW)/body weight (BW) ratio (reflecting malnutrition) exerted a negative effect, whereas the extracellular water (ECW)/BW ratio (reflecting overhydration) had a positive effect on BNP and NT-proBNP concentrations. HsCRP and cTnT concentrations were significantly associated with each other. Furthermore, NT-proBNP concentrations were predictive of cTnT and hsCRP concentrations.
Conclusions:
In the present study, we find a significant relation between BIA-derived BC parameters and natriuretic peptide concentrations. This relationship was independent of the cardiac history of the patient and suggests that the natriuretic peptide levels are to some degree modifiable by changing a patient's fluid distribution. Moreover, cTnT, BNP, NT-proBNP and hsCRP were significantly related, showing a complex relation between overhydration, malnutrition, inflammation and cardiac biomarkers in dialysis patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics